CHOLOGRAFIN SODIUM
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Apr 1954
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CHOLOGRAFIN SODIUM is an injectable diagnostic contrast agent approved in 1954 for radiographic imaging procedures. The exact mechanism and therapeutic indications are not fully specified in available data, but as a legacy injectable, it likely functions as a contrast medium for diagnostic imaging. This is a mature, established product from Bracco with limited modern clinical development.
LOE Approaching
This legacy product faces imminent loss of exclusivity with minimal current commercial activity; the brand team is likely in maintenance mode focused on sustaining existing demand rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CHOLOGRAFIN SODIUM offers limited career advancement opportunity given the product's mature lifecycle and approaching loss of exclusivity. This role is best suited for professionals focused on cost containment, market stability, and operational excellence rather than innovation or commercial scaling.
Brand ManagerField Sales Representative
Worked on CHOLOGRAFIN SODIUM at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.